FDA.reportPublic FDA data

Application 209204

Type
ANDA
Sponsor
TARO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IBUPROFENIBUPROFENSUSPENSION;ORAL100MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0121-0918IbuprofenIbuprofenPharmaceutical Associates, Inc.ANDACurrent
0121-0918IbuprofenIbuprofenPharmaceutical Associates, Inc.ANDACurrent
0121-0918IbuprofenIbuprofenPharmaceutical Associates, Inc.ANDACurrent
51672-1385IbuprofenIbuprofenTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
51672-1385IbuprofenIbuprofenTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
51672-1385IbuprofenIbuprofenTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
51672-1385IbuprofenIbuprofenTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
51672-1409IbuprofenIbuprofenTaro Pharmaceuticals U.S.A., Inc.ANDACurrent
68788-7268IbuprofenIbuprofenPreferred Pharmaceuticals Inc.ANDACurrent
68788-7268IbuprofenIbuprofenPreferred Pharmaceuticals Inc.ANDACurrent
68788-7268IbuprofenIbuprofenPreferred Pharmaceuticals Inc.ANDACurrent